My Trading Account β†’
β–Ύ
Trading Profile Active
Active Trader
Verified Trader
⚑ My $100K Trading Account β†’ β˜… My Saved Watchlist β†’
🟒 My $100K Account β†’ Today Screener Big Ideas Track Record πŸ’° $100K Arena 🎲 Predictions πŸ›οΈ Insiders 8 Analysts

Mobile-health Network Solutions (Class A) (MNDR) Options Positioning, Max Pain & Unusual Sweeps

$0.96 -2.01% NASDAQ β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $0.95

Mobile-health Network Solutions (Class A) (MNDR) carries a Roarable Rating of E (Strong Sell) with 27/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E β€’ RED ALERT Cap $3.6M
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on MNDR Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is MNDR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-03, Mobile-health Network Solutions (Class A) (NASDAQ: MNDR) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 27/100 at a spot price of $0.96 (-2.01% 1D, market cap $3.6M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 7/20, and Executive Insider Alignment 3/20. Across 715 tracked Technology issuers, MNDR ranks #648 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does MNDR compare to AMST and WCT in the Technology sector?
β–Ό

Within the Technology sector (Computer Software: Prepackaged Software), MNDR carries a Roarable E (27/100 RQD), trailing P/E of N/A, gross margin of 16.7%, and ROIC of -35.0%. By comparison, AMST (Amesite Inc.) holds a E grade (32/100 RQD, P/E N/A, ROIC -35.0%, cap $3.7M) and WCT (Wellchange Holdings Company Limited (Class A)) posts a E grade (19/100 RQD, P/E N/A, ROIC -35.0%, cap $3.2M). Among the 5-stock peer group, MNDR leads on earnings multiple (N/A) while MNDR leads on capital efficiency (-35.0% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for MNDR?
β–Ό

Per MNDR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0001976695), Mobile-health Network Solutions (Class A) generated $7.6M in revenue (-45.3% YoY), -$3.4M in net income, and -$4.4M in free cash flow against $9.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $0.95 (-0.55%)🧬 Dilution Drag (+1.28% YoY Shares)βš™οΈ Cash Engine: 4/20 (E) β€’ 0% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record Warning: Scores below 50 (27/100 Β· E) historically underperformed SPY in 71% of rolling 90-day windows (-10.3% avg 90D alpha vs SPY β€’ 29.0% hit rate).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERRED ALERT β€’ E
025507510027
3-of-3 Quant Analysts Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR RQD RADARRw E Β· Rk D-
Cash (4)Whales (5)SEC (8)Macro (7)CEO (3)
Each axis scored 0–20
12M PRICE TARGET CONE-13.5% Base Target
$34 Bull$1 Base$1 Bear
πŸ“¬ FREE MNDR RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for MNDR)Realized 20D OHLCV Swing Band: Β±12.5%
Deterministic 5-Pillar Attribution (27/100 Composite)
πŸ” WHY MNDR SCORES 27/100 (E) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (30% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) β€’ Piotroski F-Score 2/9

β–² #2 Bullish Driver: Macro Regime Fit+7/20 pts (26% of score)

FRED Regime Γ— Technicals: 2% of 52W Range β€’ RSI-14 at 46.6 (NEUTRAL RANGE)

β–Ό #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+1.28% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
35
Grade E$1.46-41.8% Next Q
Q2 (-2Q)
32
Grade E$0.85+5.9% Next Q
Q3 (-1Q)
30
Grade E$0.90+6.7% Next Q
Current
27
Grade E$0.96-10.3% Hist 90D Ξ±
Trajectory: E (35) β†’ E (27)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

βš”οΈ Adversarial Opposing Case: What Could Spark a MNDR Turnaround Squeeze

Gideon Ashmere Forensic Desk β†’

While MNDR currently carries a cautious 27/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

πŸš€ Contrarian Squeeze Trigger #1

Established market leader in Technology with deep daily trading liquidity.

πŸš€ Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.29) and Max Pain ($1.01) forces dealer call-delta covering toward $34.15.

πŸš€ Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.28% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $MNDRβ€’ $4.8M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œMNDR Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”
CALL VS. PUT WHALE SHARE
β€” (No Active Options Snapshot)
Put/Call Ratio: β€” (No Active Options Snapshot)
MAX-PAIN EXPIRATION MAGNET
β€” (No Active Options Snapshot)
No active options chain max-pain snapshot on file
HISTORICAL 20D VOLATILITY SWING
Β±12.5%
Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (MNDR)

β€” (No Active Options Snapshot) β€” No unusual CBOE strike concentration anomalies recorded in the current database snapshot for MNDR.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

πŸ† Enter Free $100K Paper Arena β†’
ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring MNDR)

  • βœ“Walkthrough of MNDR's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • βœ“3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
MNDR // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -86.67%πŸ›‘οΈ HOLDING TREND SUPPORT
2026-11-03O $0.94H $0.98L $0.94C $0.96VOL 6.72M
RES: $6.07SUP: $0.51SMA50: $1.29SMA200: $3.78
$15.11$11.21$7.31$3.40$-0.50RES $6.07SUP $0.51$0.962026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

MNDR Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. -45.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on MNDR today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for MNDR. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for MNDR today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MNDR)

1. Head-to-Head Technology Peer Comparison (MNDR vs. AMST, WCT, TAOP, DFSC)

Industry: Computer Software: Prepackaged Software (222 Tracked Issuers)

Across 715 tracked Technology securities in the Roarable RQD universe, Mobile-health Network Solutions (Class A) (MNDR) ranks #648 by composite RQD confidence (27/100, grade E) and #682 by equity capitalization ($3.6M). Within this direct 5-issuer industry benchmark cohort, MNDR leads on earnings valuation at N/A trailing P/E, while MNDR leads on capital efficiency and profitability with -35.0% ROIC and 16.7% gross margin. DFSC currently holds the highest overall quantitative score in the immediate peer group at 46/100 (D) compared with MNDR at 27/100 (E).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
MNDR ACTIVE
Mobile-health Network Solutions (Class A)
E 27/100 β€” 16.7% -35.0% -2.01% $3.6M Benchmark Subject
AMST
Amesite Inc.
E 32/100 β€” β€” -35.0% +1.48% $3.7M /amst-vs-mndr β†’
WCT
Wellchange Holdings Company Limited (Class A)
E 19/100 β€” 42.7% -35.0% -6.36% $3.2M /wct-vs-mndr β†’
TAOP
Taoping Inc.
E 31/100 β€” 10.9% -35.0% +4.14% $3.1M /taop-vs-mndr β†’
DFSC
DEFSEC Technologies Inc.
D 46/100 β€” β€” β€” -13.45% $3.1M /dfsc-vs-mndr β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-06-30 β€’ CIK 0001976695 β†—

In its most recent audited fiscal period (FY2025, filed 2025-06-30), Mobile-health Network Solutions (Class A) (MNDR) reported GAAP revenue of $7.6M (-45.3% vs. FY2024 revenue of $14.0M , and -2.9% cumulative change since FY2023) , GAAP net income of -$3.4M, operating cash flow of -$4.4M, and free cash flow of -$4.4M (+32.4% YoY). On the balance sheet, MNDR closed FY2025 with $9.9M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-06-30 $7.6M -$3.4M -$4.4M -$4.4M $9.9M β€”
FY2024 (FY) 2024-06-30 $14.0M -$15.6M -$6.4M -$6.5M β€” β€”
FY2023 (FY) 2023-06-30 $7.9M -$3.2M -$2.2M -$2.2M β€” β€”

3. MNDR Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is MNDR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Mobile-health Network Solutions (Class A) (NASDAQ: MNDR) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 27/100 at a spot price of $0.96 (-2.01% 1D, market cap $3.6M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 5/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 7/20, and Executive Insider Alignment 3/20. Across 715 tracked Technology issuers, MNDR ranks #648 in composite RQD confidence.

How does MNDR compare to AMST and WCT in the Technology sector?

Within the Technology sector (Computer Software: Prepackaged Software), MNDR carries a Roarable E (27/100 RQD), trailing P/E of N/A, gross margin of 16.7%, and ROIC of -35.0%. By comparison, AMST (Amesite Inc.) holds a E grade (32/100 RQD, P/E N/A, ROIC -35.0%, cap $3.7M) and WCT (Wellchange Holdings Company Limited (Class A)) posts a E grade (19/100 RQD, P/E N/A, ROIC -35.0%, cap $3.2M). Among the 5-stock peer group, MNDR leads on earnings multiple (N/A) while MNDR leads on capital efficiency (-35.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for MNDR?

Per MNDR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0001976695), Mobile-health Network Solutions (Class A) generated $7.6M in revenue (-45.3% YoY), -$3.4M in net income, and -$4.4M in free cash flow against $9.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is MNDR trading relative to its 50-day, 200-day, and 52-week technical levels?

MNDR last traded at $0.96 (-2.01% on volume of 208,886 shares), positioning the stock -25.58% below its 50-day simple moving average ($1.29) and -74.60% below its 200-day simple moving average ($3.78). Across its 52-week range of $0.71 to $32.52, MNDR sits at the 0.8% percentile with a 14-day RSI of 46.6 (NEUTRAL RANGE) and an implied next-earnings move of Β±12.5% ($1.00 to $1.08).

ROARABLE RATING BRIEF β€’ RQD 27/100 (E) βœ“ SEC XBRL & RQD VERIFIED

MNDR β€” Mobile-health Network Solutions (Class A): What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-06-30

1. Roarable Rating Brief: What This Means to a Prospective Investor

Mobile-health Network Solutions (Class A) (MNDR) earns a live Roarable RQD composite score of 27/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $0.96 (-2.01% 1D, market capitalization $3.6M).

  • Fundamental Cash Engine (4/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of 16.7%, operating margin of β€”, and free cash flow yield of β€”.
  • Whale 13F & Options Flow (5/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (7/20) + Forensic Balance Sheet (8/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 2/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Is a NASDAQ-listed issuer in the Technology sector, Computer Software: Prepackaged Software industry..0B.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-06-30), Mobile-health Network Solutions (Class A) (MNDR) reported $7.6M in annual revenue (up from $14.0M in FY2024, -45.3% YoY) and -$3.4M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($7.9M revenue, -$3.2M net income) through FY2025, MNDR scaled operating cash flow to -$4.4M and free cash flow to -$4.4M, backed by $9.9M in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • πŸ‚ Primary Bull Case (E β€’ RQD 27/100): Established market leader in Technology with deep daily trading liquidity. Free cash flow yield of β€” and institutional whale pillar of 5/20. With Fundamental Cash Engine at 4/20 and Institutional Whale Flow at 5/20, sustained execution supports upside toward the upper end of the $0.71 – $32.52 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against β€” operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Sector correlation data beyond the Technology classification is β€” Upstream and downstream dependencies are β€” Investors should note the absence of mapped dependencies as a gap in the analysis rather than an indication of resilience.

  • Key Question #1: Can MNDR sustain or expand its β€” operating margin and -35.0% ROIC against Computer Software: Prepackaged Software peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $7.6M and free cash flow of -$4.4M, how will capital allocation balance growth reinvestment against $0 in total debt?
  • Key Question #3: How sensitive is MNDR's equity valuation to Technology capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

MNDR Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Mobile-health Network Solutions (Class A) (MNDR) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to MNDR Debate Forum (3) ↓
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

MNDR Bull vs. Bear Conversation Board β€” What's Your Call at $0.96?

πŸ‚ 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON MNDR 🐻 33% BEARISH CONVICTION
1. Pick Your Side on MNDR:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
CA CashFlowKing RQD DEBATE OPENER β€’ FCF Compounder Hunter πŸ‚ BULLISH 🎯 Target: $1.22 (+24.5%)
πŸ“Œ Pinned Debate

The Singapore platform launch is a referenced operational catalyst, and the stock has shown extreme volume-driven price spikes in recen

Here is why I am bullish on MNDR here at $0.98: The Singapore platform launch is a referenced operational catalyst, and the stock has shown extreme volume-driven price spikes in recent news coverage.. Compare MNDR's 0.0% operating margin and -35.0% ROIC against the rest of Computer Software: Prepackaged Software. As long as cash conversion holds up, dips toward $0.93 are getting bought.

EarningsSniper πŸ‚ BULL

Both sides have a point here β€” MNDR's 8/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.

CR CreditSpread_Watch RQD DEBATE OPENER β€’ Balance Sheet Analyst 🐻 BEARISH 🎯 Target: $0.76 (-22.4%)
Spot @ $0.98

Negative ROIC of -35%, FCF of -$4.4M in FY 2025, and a Piotroski F-Score of 2/9 indicate weak cash generation and forensic balance shee

I respect the product at Mobile-health Network Solutions (Class A), but the stock at $0.98 is a different story. Negative ROIC of -35%, FCF of -$4.4M in FY 2025, and a Piotroski F-Score of 2/9 indicate weak cash generation and forensic balance sheet risk.. FCF yield is 0.0% and RQD sits at 27/100 (E) β€” why pay up here when you can wait for next quarter's numbers?

LIVE TAPE